Ian Shadforth, Vice President and General Manager, has a wealth of experience in the science, strategy, and development of connected health ecosystems comprising medical and consumer hardware integrated with cloud and mobile software. Ian has pioneered a number of cutting-edge programs for large and small companies, including: Johnson and Johnson and GlaxoSmithKline. He was recently co-founder and CEO of AffirmXH Inc., a wearables company working at the intersection of consumer and medical devices.

Ian is a Cambridge-educated scientist with a doctorate in bioinformatics from Cranfield University and an MBA from the University of Dundee. He has been awarded an Enterprise Fellowship by the Royal Society of Edinburgh and the Biotechnology and Biological Sciences Research Council (BBSRC), and the Emerging Chemometrician prize by the Royal Society of Chemistry. He is co-author of the textbook Building Bioinformatics Solutions (Oxford University Press), has authored a number of well-received peer-reviewed scientific publications, and holds numerous patents in the areas of machine learning, diagnostics, and disease management.

CorVista provides actionable cardiac diagnostics at the point of care by applying advanced machine learning for more rapid and accurate diagnosis of cardiac disease.
Find Us
United States
3 Bethesda Metro Center,
Suite 700
Bethesda, MD 20814
(833) 267-8478
CorVista Health 2024 | All rights reserved
Privacy PolicyTerms of Use